Ascend Laboratories Recalls Aripiprazole Tablets Due to Potency Risk
Ascend Laboratories, LLC recalled 2,256 bottles of Aripiprazole Tablets on August 28, 2025. The recall followed reports that the drug may be superpotent, posing serious health risks. Consumers should stop using the product immediately and consult healthcare providers.
Product Details
The recalled product is Aripiprazole Tablets, USP, 10 mg, sold in 30-count bottles. The lot number is 24144162 and the expiration date is September 2027. The tablets were manufactured by Alken Laboratories Ltd., India, and distributed nationwide by Ascend Laboratories, LLC.
The Hazard
The recall stems from concerns that the Aripiprazole Tablets may be superpotent. This increased potency can lead to severe side effects and adverse reactions in patients.
Reported Incidents
There are no specific incident reports or injury counts mentioned. However, the potential for serious health risks from superpotent drugs categorizes this recall as high risk.
What to Do
Consumers and healthcare providers should stop using Aripiprazole Tablets immediately. Contact Ascend Laboratories, LLC for guidance or consult your healthcare provider.
Contact Information
For more information, reach Ascend Laboratories, LLC at their office in Parsippany, NJ. Visit the FDA's recall page for further details.